Loading chat...
MI SB0738
Bill
AI Summary
- Requires health insurers in Michigan to cover FDA-approved drugs used in cancer treatment, including genetic therapy and immunotherapy (such as CAR-T cell therapy)
- Expands coverage to include off-label drug uses for cancer treatment if ordered by a physician and supported by current medical literature and recognition from oncology organizations
- Coverage must be provided when the drug is used as part of a cancer drug regimen, regardless of whether the specific cancer type matches the FDA approval indication
- Requires physicians to obtain informed patient consent before prescribing FDA-approved drugs for off-label cancer indications
- Applies to all health insurance policies delivered, issued for delivery, or renewed in Michigan
Legislative Description
Insurance: health insurers; coverage for antineoplastic drugs; expand. Amends sec. 3406e of 1956 PA 218 (MCL 500.3406e).
Insurance: health insurers
Last Action
Referred To Committee Of The Whole
12/12/2024
Committee Referrals
Finance, Insurance, And Consumer Protection3/5/2024
Full Bill Text
No bill text available